Turtle Creek Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Sell
5,100
-2,739
-35% -$149K 0.01% 433
2026
Q1
$492K Buy
7,839
+805
+11% +$64.4K 0.04% 232
2025
Q4
$671K Buy
7,034
+679
+11% +$66.6K 0.05% 197
2025
Q3
$620K Buy
6,355
+2,285
+56% +$237K 0.06% 191
2025
Q2
$437K Buy
+4,070
New +$412K 0.05% 185
2024
Q1
Sell
-1,674
Closed -$96.8K 283
2023
Q4
$96.8K Buy
+1,674
New +$89.4K 0.03% 204

Other funds holding BSX

Turtle Creek Wealth Advisors's BSX Position: Q2 2026 in Review

Turtle Creek Wealth Advisors reduced its Boston Scientific (BSX) stake by 35% in Q2 2026, selling an estimated $149K and leaving 5,100 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #433.

Turtle Creek Wealth Advisors first reported a position in BSX in Q4 2023 and has held it in 6 quarters since. The position peaked at $671K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Turtle Creek Wealth Advisors held 5,100 shares of Boston Scientific worth $218K as of Q2 2026.
  • Turtle Creek Wealth Advisors sold 2,739 Boston Scientific shares in Q2 2026, an estimated $149K.
  • Boston Scientific made up 0.01% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #433 holding.
  • Turtle Creek Wealth Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 6 quarters since.
  • Turtle Creek Wealth Advisors's Boston Scientific position peaked at $671K in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.